Condition: Ovarian Neoplasms · Endometrial Neoplasms · Uterine Cervical Neoplasms · Sponsor: Eli Lilly and Company
The purpose of this study is to find out whether the study drug, LY4170156, is safe, tolerable and effective in participants with advanced solid tumors. The study is conducted in two parts - phase Ia (dose-escalation, dose-optimization) and phase Ib (dose-expansion). The study will last up to approximately 4 years.
This description comes directly from the study's public registry record.
Trial questions or participation questions: 1-877-CTLILLY (1-877-285-4559) or · 1-317-615-4559 · LillyTrials@Lilly.com
Physicians interested in becoming principal investigators please contact · clinical_inquiry_hub@lilly.com
Always discuss trial participation with your own doctor first.
| HonorHealth | Scottsdale, Arizona, United States | Recruiting |
| University of California, San Diego (UCSD) - Moores Cancer Center | La Jolla, California, United States | Recruiting |
| South Texas Accelerated Research Therapeutics (START) Midwest | Grand Rapids, Michigan, United States | Recruiting |
| NYU Langone Health - Long Island | Mineola, New York, United States | Recruiting |
| New York University (NYU) Clinical Cancer Center | New York, New York, United States | Recruiting |
| David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center | New York, New York, United States | Recruiting |
| The Ohio State University (OSU) Wexner Medical Center | Columbus, Ohio, United States | Recruiting |
| The University of Texas - MD Anderson Cancer Center | Houston, Texas, United States | Recruiting |
| START Mountain Region | West Valley City, Utah, United States | Recruiting |
| Cancer Research SA | Adelaide, Australia | Recruiting |
| Icon Cancer Centre South Brisbane | QLD, Australia | Recruiting |
| Centre Leon Berard | Lyon, France | Recruiting |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06400472